Jon-Emile Kenny, chief medical officer at Flosonics Medical. “We’re thrilled to partner with El Camino Health to launch this pioneering ultrasound technology,” said Dr. One recent study showed that up to half of patients may avoid potentially dangerous fluid overloading in emergency departments when the FloPatch is used. Jon-Emile Kenny, chief medical officer, Flosonics Medical Our nurses immediately loved it, and helped decide where in the hospital the technology would be the best fit.” “We are proud to be the first hospital in the world to adopt this advanced technology, and have been working with Fogarty Innovation and Flosonics Medical for the past year piloting FloPatch. “Timing is crucial when caring for patients with sepsis,” Reinking said. Food and Drug Administration-approved device provides a simple way to measure changes in how the heart is performing, hospital officials said, explaining it works by checking on blood flow in the carotid arteries, the pathways to the brain, neck and face. ![]() ![]() ![]() “Our nurses have seen firsthand how effective FloPatch is in monitoring the effectiveness of treatment in deteriorating patients,” said Cheryl Reinking, chief nursing officer at El Camino Health, in a release, adding, “-especially those with sepsis and low blood pressure.” The new addition to their tool kit is the FloPatch, a piece of ultrasound equipment that live-monitors blood flow and is meant to assist with managing IV therapy. El Camino Health has become the first organization in the world to adopt a new technology created by Canadian company Flosonics Medical to boost care for patients suffering from sepsis and similar conditions.
0 Comments
Leave a Reply. |